In this episode, Dr. Stader and Dr. Bradley summarize and offer key insights for the following Coaches' Top 5 picks, discussing injectable buprenorphine, benzodiazepine tapering, advances in the prevention of migraine, and more!
Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths, Published in the New England Journal of Medicine, June 2024
Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal, Published in JAMA, July 2024
Physician Reluctance to Intervene in Addiction: A Systematic Review, Published in JAMA Network Open, July 2024
ASAM Guideline on Benzodiazepine tapering, Published by ASAM, July 2024
Pharmacologic prevention of migraine, Published in the Canadian Medical Association Journal, February 2023
